152 related articles for article (PubMed ID: 27627102)
1. Soybean Oil-Based Lipid Emulsion Increases Intestinal Permeability of Lipopolysaccharide in Caco-2 Cells by Downregulation of P-Glycoprotein via ERK-FOXO 3a Pathway.
Yan JK; Zhu J; Gu BL; Yan WH; Xiao YT; Zhou KJ; Wen J; Wang Y; Cai W
Cell Physiol Biochem; 2016; 39(4):1581-94. PubMed ID: 27627102
[TBL] [Abstract][Full Text] [Related]
2. Sodium butyrate attenuates soybean oil-based lipid emulsion-induced increase in intestinal permeability of lipopolysaccharide by modulation of P-glycoprotein in Caco-2 cells.
Yan JK; Gong ZZ; Zhang T; Cai W
Biochem Biophys Res Commun; 2017 Jan; 482(4):791-795. PubMed ID: 27888107
[TBL] [Abstract][Full Text] [Related]
3. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic analysis for drug permeation through intestinal membrane.
Hayashi M; Tomita M
Drug Metab Pharmacokinet; 2007 Apr; 22(2):67-77. PubMed ID: 17495413
[TBL] [Abstract][Full Text] [Related]
5. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
6. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
7. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
[TBL] [Abstract][Full Text] [Related]
8. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
[TBL] [Abstract][Full Text] [Related]
9. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
Wu SJ; Robinson JR
Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
11. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-beta-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers.
Arima H; Yunomae K; Morikawa T; Hirayama F; Uekama K
Pharm Res; 2004 Apr; 21(4):625-34. PubMed ID: 15139519
[TBL] [Abstract][Full Text] [Related]
12. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
13. Potential P-glycoprotein-mediated herb-drug interaction of phyllanthin at the intestinal absorptive barrier.
Dunkoksung W; Vardhanabhuti N; Jianmongkol S
J Pharm Pharmacol; 2019 Feb; 71(2):213-219. PubMed ID: 30251430
[TBL] [Abstract][Full Text] [Related]
14. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
[TBL] [Abstract][Full Text] [Related]
15. Influence of passive permeability on apparent P-glycoprotein kinetics.
Lentz KA; Polli JW; Wring SA; Humphreys JE; Polli JE
Pharm Res; 2000 Dec; 17(12):1456-60. PubMed ID: 11303953
[TBL] [Abstract][Full Text] [Related]
16. Early downregulation of P-glycoprotein facilitates bacterial attachment to intestinal epithelial cells and thereby triggers barrier dysfunction in a rodent model of total parenteral nutrition.
Zhang T; Liu Y; Yan JK; Cai W
FASEB J; 2020 Mar; 34(3):4670-4683. PubMed ID: 32027421
[TBL] [Abstract][Full Text] [Related]
17. Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir.
Mouly SJ; Paine MF; Watkins PB
J Pharmacol Exp Ther; 2004 Mar; 308(3):941-8. PubMed ID: 14718607
[TBL] [Abstract][Full Text] [Related]
18. Ischemia/reperfusion injury in the monolayers of human intestinal epithelial cell line caco-2 and its recovery by antioxidants.
Nagira M; Tomita M; Mizuno S; Kumata M; Ayabe T; Hayashi M
Drug Metab Pharmacokinet; 2006 Jun; 21(3):230-7. PubMed ID: 16858127
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.
Hosoya KI; Kim KJ; Lee VH
Pharm Res; 1996 Jun; 13(6):885-90. PubMed ID: 8792427
[TBL] [Abstract][Full Text] [Related]
20. The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within Caco-2 cells.
Sachs-Barrable K; Darlington JW; Wasan KM
Lipids Health Dis; 2014 Oct; 13():153. PubMed ID: 25273894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
